Research progress of succinate and atherosclerosis
DOI:
CSTR:
Author:
Affiliation:

1.Department of Cardiovascular Medicine, The Second Affiliated Hospital, University of South China, Hengyang, Hunan 421001, China;2.Institute of Cardiovascular Diseases, Hengyang Medical School, University of South China, Hengyang, Hunan 421001,China)

Clc Number:

R5

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Cardiovascular disease is the leading cause of death. Moreover, the incidence of cardiovascular disease in young/middle-aged people (18~45 years old) is still on the rise. Early diagnosis, early warning and treatment of cardiovascular disease are important topics in the current medical research field. Atherosclerosis is the pathophysiological basis of many cardiovascular diseases. Recent studies have shown that the tricarboxylic acid (TCA) cycle intermediate is involved in the occurrence and development of atherosclerosis, and considered as the early diagnosis and warning bio-markers for atherosclerosis. Here, the roles and underlying mechanisms of succinate in the initiation and progression in atherosclerosis were reviewed.

    Reference
    Related
    Cited by
Get Citation

ZENG Yan, WEI Dangheng, ZENG Gaofeng. Research progress of succinate and atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(1):83-87.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 26,2021
  • Revised:November 28,2021
  • Adopted:
  • Online: January 07,2022
  • Published:
Article QR Code